CHDI FOUNDATIONCHDI

Accelerating Therapeutic Development for Huntington's Disease

  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel
  • Preclinical research
  • Scientific Publications
  • Community Resources
    • Materials
      • Research tools & reagents
      • Mouse Models
      • Clinical biorepository
    • Data sharing & infomatics
      • Preclinical informatics: HDinHD
    • Funding & partnerships
      • Academic Proposals
      • External Partnership Proposals
    • HD expertise & guidance
      • Independent Statistical Standing Committee
      • Clinical outcomes: Rating scales
      • Field guide to HD mouse models
  • News & Video
    • News
    • HD Therapeutics Conference
      • 2025 Presentations
      • 2024 Presentations
      • 2023 Presentations
      • 2022 Presentations
      • 2021 Presentations
      • 2020 Presentations
      • 2019 Presentations
      • 2018 Presentations
      • 2017 Presentations
      • 2016 Presentations
      • 2015 Presentations
      • 2014 Presentations
      • 2013 Presentations
      • 2012 Presentations
      • 2011 Presentations
    • Postcards
    • Events
  • About Us
    • The Foundation
    • People
    • Policies
      • Data, Reagents, and Biomaterials Sharing Policy
      • Publication Policy
      • Reimbursement of Publication Costs
      • Financial Support for Conferences, Meetings, or Workshops
      • Academic Overhead
      • Academic Salary Limits
      • Leave of Absence Policy
      • Eligible Personnel

March 14, 2014

A Field Guide to Working with Mouse Models of Huntington’s Disease

Many different mouse models of Huntington’s disease are now available and the choice of which model(s) to use is a critical consideration that depends greatly on your particular research focus. Equally, good husbandry to breed and rear mouse colonies under rigorous quality-controlled conditions can ensure genetic integrity and the highest quality resources for HD research, which is integral to generating robust and reproducible results that can be compared across laboratories.

CHDI, The Jackson Laboratory, and PsychoGenics, Inc. have compiled A Field Guide to Working with Mouse Models of Huntington’s Disease that brings together current understanding of many of the established and emerging HD mouse models and their known advantages, disadvantages, peculiarities and pitfalls, and proposes standardized best practices to optimize their use in preclinical research and development. In particular, the manual emphasizes the importance of understanding how different models reflect disease phenotypes and mechanisms; the ‘best model’ to use will depend on the question being addressed. The goal is to improve the translation of results to the clinic and accelerate the pace of HD therapeutic research.

Topics covered include:

  • Common and emerging mouse models for Huntington’s disease research
  • Quality control criteria and recommended best practices for using HD mouse models
  • Model peculiarities, pitfalls, and considerations
  • Best practices for using HD mouse models to test compound efficacy

You can download a copy here. We intend this field guide to be a collective HD community resource that will be updated periodically, so we welcome and encourage feedback from all HD researchers to improve and broaden content. Please contact CHDI at

A webinar series to discuss the field guide will be held on Thursday March 20th 2014 at 1pm EDT*, you can sign up here.

Presenters:

  • Liliana Menalled, Ph.D., PsychoGenics, Inc.
  • David Howland, Ph.D., CHDI Foundation
  • Cathleen Lutz, Ph.D., The Jackson Laboratory

Moderator:

  • Charles Miller, Ph.D., The Jackson Laboratory

* To convert times and dates to your location use a Time Zone Map website such as this one (ET in the US is the same as New York City, New York).

Important note: Webinar attendance is assured only for participants who register at least 1 hour prior to scheduled start time

Post navigation

← Video Postcard from 2014 HD Therapeutics Conference Huntington’s Disease Society of America endorses Enroll-HD →
Connect with CHDI

Send Feedback

We appreciate any comments or questions on this page—our goal is to make this concise and helpful.

Join Our Mailing List
Terms of Use
Privacy Policy
Cookie Policy
Creative Commons License
Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 Unported License.

Click to read a letter from Robert Pacifici, CHDI CSO, regarding COVID-19